• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Applied BioSciences Expands TherPet Line with Equine Care Line

May 9, 2018

 

Los Angeles, CA -- May 9, 2018 -- /D.M.O. Newswire/ -- Applied BioSciences Corp. (OTC:APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, today announced that the Company's wholly-owned animal health subsidiary TherPet has entered the equine health space with the launch of a new full-spectrum hemp-derived cannabidiol ("CBD") supplement formulated specifically for a horse's health and wellness.

 

TherPet's Equine Care CBD line is a natural supplement designed to play a key role in keeping horses, healthy, looking good and performing their best. Our Equine Care CBD products support healthy skin, joints and immune system as well as to ease the discomfort of fatigued muscles, stiff joints and arthritis pain.

Like humans, horses also have an endocannabinoid system comprised of cannabinoid receptors that help regulate a wide variety of bodily functions ranging from pain relief to mood.

 

"Regularly supplementing a horse's endocannabinoid system with full-spectrum CBD enables horses to better control inflammatory responses naturally," noted JJ Southard, Vice President of Products at Applied BioSciences Corp. "Despite millions of spectators tuning in to watch twenty of the fastest thoroughbred horses compete in the Kentucky Derby this past weekend, very few of them realize or consider the race-induced inflammation and injuries that take place during such an event."

 

David Horohov, Ph.D., William Robert Mills Chair at the University of Kentucky's Gluck Equine Research Center, believes that horses as a breed are not necessarily becoming more fragile, but rather more susceptible to injury due to breeding strategies, training methods, and increased drug use. The Company hopes to reverse this trend by making Therpet's new treatment options available immediately for veterinarians, trainers, and equestrians.

 

Therpet's Equine Care tincture is available in a 4800 mg concentration which is packaged in a 4 fl. Oz. (120ml) bottle. The tincture is a naturally formulated Apple flavor, made with lab tested, CO2 extracted, pure full-spectrum CBD oil sourced from pesticide-free, Colorado grown hemp and specially formulated to be the highest bioavailability CBD products in the marketplace.

 

TherPet products are USDA NOP certified organic, non-GMO, vegan, paleo, gluten-free, sugar-free and THC-free. The products are formulated with organic 99%+ pure cannabidiol along with our proprietary blend of certified organic botanical, herbal and essential oils to further optimize bioavailability.

 

About Applied BioSciences Corp.

 

Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

 

The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.

 

Contact

 

Email: ir@appliedbiocorp.com or info@appliedbiocorp.com

To be added to the Applied BioSciences email distribution list, please email info@appliedbiocorp.com with APPB in the subject line.

Official Website: www.appliedbiocorp.com

 

Brands:

 

www.remedishop.com

www.therpet.com

 

Follow us:

 

Facebook @remedicbd & @therpetcbd
Instagram @remedicbd & @therpet
Twitter @remedishop & @therpet

 

Safe Harbor Statement

 

Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Applied Biosciences Corp. (the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.